QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Activity

15 hedge funds and large institutions have $69K invested in Qualigen Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TRCT
1
Tower Research Capital (TRC)
New York
$4.2K
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$466
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$351
4
Wells Fargo
4
Wells Fargo
California
$33

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$1.25K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$20.2K
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$23.5K 25,840 – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$20.2K 22,152 -177 -0.8%
State Street
3
State Street
Massachusetts
$9.96K 10,930 – –
HWM
4
HighMark Wealth Management
Minnesota
$7.3K 8,009 – –
TRCT
5
Tower Research Capital (TRC)
New York
$4.2K 4,609 +2,627 +133%
UBS Group
6
UBS Group
Switzerland
$1.25K 1,370 -9,907 -88%
US Bancorp
7
US Bancorp
Minnesota
$751 824 – –
Fidelity Investments
8
Fidelity Investments
Massachusetts
$466 512 +512 New
Group One Trading
9
Group One Trading
Illinois
$385 423 – –
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$351 385 +385 New
RG
11
Retirement Group
California
$319 350 – –
IGWM
12
ICA Group Wealth Management
Colorado
$223 245 – –
Wells Fargo
13
Wells Fargo
California
$33 36 +7 +24%
AIC
14
Archer Investment Corporation
Indiana
$15 16 – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$0 4 – –
CFGS
16
Concourse Financial Group Securities
Alabama
– – – –